StockWatch
·

Sudarshan Pharma Industries Ltd Q3 FY26 Results

SUDARSHANQ3 FY26 Results
Filing
MetricValue ( Cr)vs Q2 FY26
Revenue168.010.5%
Total Income169.520.7%
Expenditure164.331.3%
PBT5.2022.9%
Net Profit4.157.1%
OPM6.47%1.02pp
NPM2.45%0.18pp
EPS0.1812.5%
View full financials

Informational and educational content only. Not investment advice.